1 / 15

Formal lab report

Formal lab report. Rough draft due Friday (2 copies, please) ¿ Any questions? Figures. Today’s lab. Measure V o vs. [S] for fumarate (fwd rxn) or malate (rvs rxn) For everyone: +/- citrate (reversible inhibitor) Fumarate: you want to start ~ same absorbance

azize
Download Presentation

Formal lab report

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Formal lab report • Rough draft due Friday (2 copies, please) • ¿Any questions? • Figures

  2. Today’s lab • Measure Vo vs. [S] for fumarate (fwd rxn) or malate (rvs rxn) • For everyone: +/- citrate (reversible inhibitor) • Fumarate: you want to start ~ same absorbance • Molar absorptivity depends on wavelength • Higher initial concentrations: use wavelength where fumarate absorbs more weakly • Malate: measure at 240nm

  3. Kinetics & Reversible Inhibition • Determine mechanism of inhibition • Competitive (alter binding, raise apparent Km) • Non-competitive (alter catalysis, lower apparent Vmax) • Determine potency of inhibition • Ki: “Inhibition constant” • Lower Ki means more potent inhibitor

  4. Mechanism of inhibition • Competitive: • Inhibitor competes with substrate for binding to the active site • Inhibitor binds FREE ENZYME • Inhibitor must “look like” substrate • Note: when [S] >> [I], inhibitor has no effect (ie. competitive inhibitor has no effect on Vmax)

  5. Mechanism of inhibition • Competitive: • Inhibition constant Ki EI ↔ E + I • Lower Ki = stronger affinity ie. more potent inhibitor (inhibits at lower concentrations)

  6. Mechanism of inhibition • Mixed (eg. Non-competitive) • Inhibitor binds somewhere else (not active site) • Bind either E or ES (to form EI or ESI complexes) • Mixed alter both Km and Vmax • Pure non-comp alter Vmax, but don’t influence Km

  7. Mechanism of inhibition • Mixed (eg. Non-competitive) • Since “Ki” describes two potential equilibria, harder to get a handle on • But still, lower Ki ~ stronger inhibitor

  8. Lineweaver-Burk plot Y-intercept = 1/Vmax X-intercept = -1/Km Competitive inhibitor affects Km, not Vmax L-B plot: same y-intercept, x-intercept moves to the right Kinetics to determine type and potency of inhibition

  9. Non-competitive inhibitor Affects Vmax (moves y-intercept up) Doesn’t affect Km (x-intercept same)

  10. Determining Ki • Need to know type of inhibition • Competitive: • Slope is increased by (1+[I]/Ki) • So, make L-B plot at 0 inhibitor and compare its slope to the slope at one or more inhibitor concentrations to determine Ki

  11. Determining Ki • Need to know type of inhibition • Non-competitive: Vmax in the presence of inhibitor ~ V‘max • So, determine Vmax with no inhibitor, then apparent Vmax values at one or more inhibitor concentrations

  12. Determining Ki • Can’t directly compare Ki values for different types of inhibitors, but gives you some idea of their potency (~ Kd) • Need to know type of inhibition before calculating Ki

  13. Irreversible inhibitors • Potential for higher effectiveness • Permanently inhibit an enzyme or take it completely out of commission • Drug discovery • “Suicide inhibitors” • Also takes the inhibitor out of commission

  14. Irreversible inhibitors • Mechanism-based inhibitor • Acts like a substrate during initial parts of the reaction • Often (always) forms covalent bond with enzyme • Insensitive to later steps • “Stalls” before release • Good for studying enzyme mechanisms

  15. Doesn’t look at all like a peptide bond, but reacts with Ser195 Enzyme can’t complete the reaction Active site permanently blocked Chymotrypsin vs. DIFP

More Related